← FDA Drug Approvals (Drugs@FDA)
ERYTHROMYCIN LACTOBIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NEXUS · Approved 2022-02-14
Drug application
- FDA Application #
ANDA215290- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ERYTHROMYCIN LACTOBIONATE
- Generic name
- Erythromycin Lactobionate
- Active ingredients
- ERYTHROMYCIN LACTOBIONATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- NEXUS
- First approval
- 2022-02-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown